Clinical trial
Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected…
NCT00003434 · Duke University, Other · Terminated
Key facts
| NCT number | NCT00003434 |
|---|---|
| Title | Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer |
| Official title | A Pilot Study of Active Immunotherapy With Carcinoembryonic Antigen Peptide-Pulsed, Autologous Human Cultured Dendritic Cells in Patients With Resected, Stage I, II and III Pancreatic Adenocarcinoma Expressing Carcinoembryonic Antigen |
| Lead sponsor | Duke University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological |
| Interventions | carcinoembryonic antigen peptide 1, hepatitis B antigen peptide |
| Enrollment | 8 |
| Start date | Jun 1, 1998 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Apr 27, 2004 |
| Last update posted | Feb 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: